Evidence map›Paper›PMID 27026365›Full record

ArticleJournal of the American Society of Nephrology : JASN2016

Kt/Vurea and Nonurea Small Solute Levels in the Hemodialysis Study.

Timothy W Meyer, Tammy L Sirich, Kara D Fong, Natalie S Plummer, Tariq Shafi, Seungyoung Hwang, Tanushree Banerjee, Yunnuo Zhu, Neil R Powe, Xin Hai and 1 more

Open access · greenAbstract read
In one paragraph

Article in Journal of the American Society of Nephrology : JASN, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
8.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 58 citations in OpenAlex.

  1. Contribution of 'clinically negligible' residual kidney function to clearance of uremic solutes.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2020
    Trial
  2. Trial
  3. Trial
  4. Review
  5. Article
  6. Article
  7. Article
  8. Twice Weekly versus Thrice Weekly Hemodialysis-A Pilot Cross-Over Equivalence Trial.Clinical journal of the American Society of Nephrology : CJASN · 2024
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Blood Microbiome in CKD: Should We Care?Clinical journal of the American Society of Nephrology : CJASN · 2019
    Article
  16. Protein carbamylation in end stage renal disease: is there a mortality effect?Current opinion in nephrology and hypertension · 2018
    Review
  17. Article
  18. Review
  19. Review
  20. Extended Duration Nocturnal Hemodialysis and Changes in Plasma Metabolite Profiles.Clinical journal of the American Society of Nephrology : CJASN · 2018
    Observational
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

Timothy W MeyerDepartment of Medicine, Palo Alto Veterans Affairs Health Care System and Stanford University, Palo Alto, California; twmeyer@stanford.edu.
Tammy L SirichDepartment of Medicine, Palo Alto Veterans Affairs Health Care System and Stanford University, Palo Alto, California.
Kara D FongDepartment of Medicine, Palo Alto Veterans Affairs Health Care System and Stanford University, Palo Alto, California.
Natalie S PlummerDepartment of Medicine, Palo Alto Veterans Affairs Health Care System and Stanford University, Palo Alto, California.
Tariq ShafiDepartment of Medicine and Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins University, Baltimore, Maryland.
Seungyoung HwangDepartment of Medicine and Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins University, Baltimore, Maryland.
Tanushree BanerjeeDepartment of Medicine, University of California, San Francisco, California; and.
Yunnuo ZhuDepartment of Medicine, University of California, San Francisco, California; and.
Neil R PoweDepartment of Medicine, University of California, San Francisco, California; and.
Xin HaiDepartment of Medicine, Case Western Reserve University, Cleveland, Ohio.
Thomas H HostetterDepartment of Medicine, Case Western Reserve University, Cleveland, Ohio.
University of California, San Francisco · USCase Western Reserve University · USJohns Hopkins University · USStanford University · USVA Palo Alto Health Care System · US

Funding

Retained Organic Solutes and Clinical Outcomes in HemodialysisR01DK080123 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI POWE, NEIL R. · 2008 to 2012
$3.2M
Residual Kidney Function in ESRD: Measurements, Serum Markers and OutcomesK23DK083514 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI SHAFI, TARIQ · 2010 to 2014
$904k
New Solutes to Assess Kidney DiseaseIK2CX001036 · VA · VETERANS ADMIN PALO ALTO HEALTH CARE SYS · PI SIRICH, TAMMY LISA · 2014 to 2018
–
CSRD VA IK2 CX001036NIDDK NIH HHS K23 DK083514NIDDK NIH HHS R01 DK080123
6 · The paper itself

Abstract

The Hemodialysis (HEMO) Study showed that high-dose hemodialysis providing a single-pool Kt/V

Indexed as

Renal DialysisFemaleHemodialysis SolutionsHumansMaleMiddle AgedUreaHemodialysis SolutionsUreahemodialysishemodialysis adequacyuremia

Identifiers

PMID27026365
PMCPMC5084890
OpenAlexW2319187512

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.